Cargando…

Side effects related to systemic cancer treatment: are we changing the Promethean experience with molecularly targeted therapies?

Detalles Bibliográficos
Autor principal:	De Angelis, Carlo
Formato:	Texto
Lenguaje:	English
Publicado:	Multimed Inc. 2008
Materias:	Invited Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2528304/ https://www.ncbi.nlm.nih.gov/pubmed/18769606

Ejemplares similares

Opportunities and risks of ChatGPT in medicine, science, and academic publishing: a modern Promethean dilemma
por: Homolak, Jan
Publicado: (2023)

Mastery Without Mystery: Why there is no Promethean Sin in Enhancement
por: Kahane, Guy
Publicado: (2011)

Regenerative medicine: the promises and perils of a Promethean task
por: Moldovan, Nicanor I
Publicado: (2010)

Towards retrieving the Promethean treasure: a first molecular assessment of the freshwater fish diversity of Georgia
por: Epitashvili, Giorgi, et al.
Publicado: (2020)

Predicting the outcome of normal pressure hydrocephalus therapy—where do we stand?
por: Oertel, Joachim M. K., et al.
Publicado: (2021)

Clinical experiences with molecular targeted therapy in lung cancer in China
por: Wang, Yan, et al.
Publicado: (2015)

What do the “new” Pulmonary Hypertension Guidelines tell us: should we change our practice?
por: Kaymaz, Cihangir, et al.
Publicado: (2016)

Do We Have the Spark?
por: Rupel, Valentina Prevolnik, et al.
Publicado: (2022)

Prevention of cardiovascular disease: are we successful?( )
por: De Backer, Guy
Publicado: (2022)

Predatory Journals, Fake Conferences and Misleading Social Media: The Dark Side of Medical Information
por: Kert, Suzana, et al.
Publicado: (2021)

Vaginal mesh: What lessons have we learnt?
por: Robinson, Dudley, et al.
Publicado: (2020)

Molecular Targets for Endometriosis Therapy: Where We Are and Where We Are Going?
por: Barra, Fabio, et al.
Publicado: (2019)

Prostate cancer: molecular and cellular mechanisms and their implications in therapy resistance and disease progression
por: Feng, Ninghan, et al.
Publicado: (2019)

Do we always need anticoagulation before cardioversion of atrial fibrillation in ladies?
por: Görenek, Bülent, et al.
Publicado: (2016)

Doctors and COVID-19: Why we need to be a wise human first!
por: Gore, Gouri Adwaita
Publicado: (2020)

Poor Clinician Adherence to Inflammatory Bowel Disease Guidelines: How Do We Remedy the Situation?
por: Hart, Lara, et al.
Publicado: (2022)

World Heart Federation Policy Brief: Front-Of-Pack Labelling: Unhealthy Changes in the Global Food System
por: Champagne, Beatriz, et al.
Publicado: (2020)

Landslides behavior spatial modeling by using evidential belief function model, Promethean II model, and index of entropy in Tabriz, Iran
por: Beheshti, Ziba, et al.
Publicado: (2021)

Providing Pneumococcal Vaccines Reduces the Risk of Serious Infections From Pneumococcal Pneumonia. We Should Consider a Simplified Immunization Schedule
por: Almasry, Mazen, et al.
Publicado: (2023)

Editorial: gut microbial profile associated with primary sclerosing cholangitis—what is new and how do we progress from here? Authors’ reply
por: Rühlemann, Malte, et al.
Publicado: (2019)

Advancing global change biology through experimental manipulations: Where have we been and where might we go?
por: Hanson, Paul J., et al.
Publicado: (2019)

Targeting cytokine storm in COVID-19: what have we learned?
por: Ridker, Paul M
Publicado: (2021)

Molecular targeted agents—where we are and where we are going
por: Yan, Li
Publicado: (2013)

Controversies in testosterone supplementation therapy
por: Khera, Mohit
Publicado: (2015)

We need to talk about Covid-19 pandemic related stress
por: Obeng-Gyasi, Samilia
Publicado: (2022)

Menopausal hormone therapy and ovarian cancer
por: Baber, Rod
Publicado: (2015)

Fat tissues, the brite and the dark sides
por: Chen, Yong, et al.
Publicado: (2016)

Genetic hearing loss: the journey of discovery to destination – how close are we to therapy?
por: Pandya, Arti
Publicado: (2016)

Conclusions about testosterone therapy and cardiovascular risk
por: Anawalt, Bradley D, et al.
Publicado: (2018)

A fight with SARS-Cov-2 infection (COVID-19): Experience of an orthopedic surgeon
por: Vaishya, Raju
Publicado: (2020)

Will an International Qualitative Study of Crohn’s Disease Patient Experiences and Preferences Evolve the Future of Disease Monitoring?
por: Castrillon, Rocio
Publicado: (2023)

The Winning Line Up: Positioning Advanced Therapies for Ulcerative Colitis
por: Forster, Erin M
Publicado: (2023)

Use of novel drug therapies during pregnancy and breast-feeding
por: Ayuk, Paul T.-Y.
Publicado: (2023)

Menopausal hormone therapy and breast cancer risk: All progestogens are not the same
por: Lambrinoudaki, Irene
Publicado: (2020)

Bronchopleural fistula treatment: From the archetype of surgery to the future of stem cell therapy
por: Petrella, Francesco, et al.
Publicado: (2015)

Postmenopausal bleeding: Which endometrial thickness is safe in menopausal hormone therapy users?
por: Dreisler, Eva
Publicado: (2022)

2022: the year in cardiovascular disease – the year of upfront lipid lowering combination therapy
por: Banach, Maciej, et al.
Publicado: (2022)

Research and Critical Thinking : An Important Link for Exercise Science Students Transitioning to Physical Therapy
por: WALLMANN, HARVEY W., et al.
Publicado: (2012)

Breaking the Therapeutic Ceiling: Dual Biologic or Small Molecule Therapy for Refractory Inflammatory Bowel Disease
por: Ahmed, Waseem
Publicado: (2022)

San Antonio Breast Cancer Symposium 2007—Adjuvant endocrine therapy update: ATAC 100 highlights
por: Joy, Anil A.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_p2q1inu6iigmcm8gqdek41pul3